Goldman Sachs
KMTS icon

Goldman Sachs’s Kestra Medical Technologies KMTS Stock Holding History

Goldman Sachs’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.74M Buy
304,384
+16,030
+6% +$336K ﹤0.01% 3482
2026
Q1 		$5.75M Buy
288,354
+15,902
+6% +$375K ﹤0.01% 3568
2025
Q4 		$7.23M Buy
272,452
+200,130
+277% +$5.15M ﹤0.01% 3399
2025
Q3 		$1.72M Buy
72,322
+56,492
+357% +$1.01M ﹤0.01% 4602
2025
Q2 		$262K Buy
+15,830
New +$346K ﹤0.01% 5518

Other funds holding KMTS

Bain Capital Investors
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Goldman Sachs's KMTS Position: Q2 2026 in Review

Goldman Sachs increased its Kestra Medical Technologies (KMTS) stake by 5.6% in Q2 2026, buying an estimated $336K and bringing the position to 304,384 shares worth $7.74M. The position accounts for ﹤0.01% of the portfolio, ranked #3482.

Goldman Sachs first reported a position in KMTS in Q2 2025 and has held it in 5 quarters since. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Goldman Sachs held 304,384 shares of Kestra Medical Technologies worth $7.74M as of Q2 2026.
  • Goldman Sachs bought 16,030 Kestra Medical Technologies shares in Q2 2026, an estimated $336K.
  • Kestra Medical Technologies made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3482 holding.
  • Goldman Sachs first reported a position in Kestra Medical Technologies in Q2 2025 and has held it in 5 quarters since.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.